The MRC funding will help with the next steps, including equipment needed to manufacture experimental mRNA cancer vaccines and test whether the AI’s predictions work in patient samples. The aim is to determine whether vaccine targets selected by AI can generate strong anti-cancer immune responses.
Source link
Top News
Friday , 5 June 2026
Friday , 5 June 2026
Share
Explore more
Related Articles
Artificial intelligence
Top Robotics Stocks Worth Investing in the Second Half of 2026
An updated edition of the April 16, 2026, article. The American robotics industry...
Artificial intelligence
Expert’s horror warning for how AI will end the world and ‘destroy humanity’ | World | News
An expert on Artificial Intelligence issued a horror warning that the technology...
Artificial intelligence
How Anthropic, OpenAI and Nvidia Are Driving the AI Economy
Artificial intelligence apps are quickly becoming ubiquitous — for personal and enterprise use...
Artificial intelligence
How Lumo uses machine learning to streamline E&L screening
In this interview, industry expert Dr. Anthony Grice explains how machine learning...
Leave a comment